Safety and Efficacy of Human Mesenchymal Stem Cells for Treatment of Liver Failure

Clinical trial NCT01218464 · UNKNOWN

Trial details

NCT number: NCT01218464
Sponsor: Beijing 302 Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Liver Failure Mesenchymal Stem Cells

Start date: 2009-03-01
Primary completion: 2014-03-01
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.